Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-27 @ 10:15 AM
Study NCT ID:
NCT00910104
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2009-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cholestasis Reversal: Efficacy of IV Fish Oil
Sponsor:
Mark Puder
Organization:
Study Overview
Official Title:
Cholestasis Reversal: Efficacy of IV Fish Oil
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Reversal
Brief Summary:
The purpose of this study is to determine whether Omegaven is effective in the treatment of parenteral nutrition associated liver disease (PNALD).
Detailed Description:
The purpose of this study is to determine whether the omega-3 fatty acid emulsion (Omegaven), when used in lieu of the conventional soy-based fat emulsion (Intralipid), is effective in the treatment of parenteral nutrition associated liver disease (PNALD).
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 1R01FD003460-02 | FDA | None | https://reporter.nih.gov/quic… | View |